Sommaire

• • ·Editorial board

    Page :IFC

    
• • ·Corrigendum to “A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients” [Pulm Pharmacol Ther 25 (3) (2012) 248–253]

    Page :305

    D. Singh, H. Magnussen, A. Kirsten, S. Mindt, C. Caracta, B. Seoane, D. Jarreta, E. Garcia Gil

    

• Original Articles

  • ·Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes

    Page :159-166

    Makoto Yoshida, Takako Nakano, Satoru Fukuyama, Takafumi Matsumoto, Miyuki Eguchi, Atsushi Moriwaki, Shohei Takata, Kentaro Machida, Akiko Kanaya, Koichiro Matsumoto, Yoichi Nakanishi, Hiromasa Inoue

    Résumé Résumé Plan Plan  
  • ·Prevention and amelioration of rodent endotoxin-induced lung injury with administration of a novel therapeutic tripeptide feG

    Page :167-171

    Alison S.F. Elder, Andrew D. Bersten, Gino T.P. Saccone, Dani-Louise Dixon

    Résumé Résumé Plan Plan  
  • ·Assessing and accessing the small airways; implications for asthma management

    Page :172-179

    Nicola Scichilone, Marco Contoli, Davide Paleari, Pietro Pirina, Andrea Rossi, Claudio Maria Sanguinetti, Pierachille Santus, Matteo Sofia, Nicola Sverzellati

    Résumé Résumé Plan Plan  
  • ·Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: Critical role of N-sulfation

    Page :180-188

    Tahir Ahmed, Gregory Smith, William M. Abraham

    Résumé Résumé Plan Plan  
  • ·Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol

    Page :189-194

    Kazuto Matsunaga, Hiroki Kawabata, Tsunahiko Hirano, Hisatoshi Sugiura, Yoshiaki Minakata, Masakazu Ichinose

    Résumé Résumé Plan Plan  
  • ·Cell cycle regulation by glucosamine in human pulmonary epithelial cells

    Page :195-204

    Kun-Han Chuang, Chih-Shen Lu, Yu Ru Kou, Yuh-Lin Wu

    Résumé Résumé Plan Plan  
  • ·A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism

    Page :205-211

    John A. Watts, Michael A. Gellar, Mary-Beth K. Fulkerson, Jeffrey A. Kline

    Résumé Résumé Plan Plan  
  • ·Statins, systemic inflammation and risk of death in COPD: The Rotterdam study

    Page :212-217

    Lies Lahousse, Daan W. Loth, Guy F. Joos, Albert Hofman, Hubert G.M. Leufkens, Guy G. Brusselle, Bruno H. Stricker

    Résumé Résumé Plan Plan  
  • ·Project PriMo: Sharing principles and practices of bronchodilator therapy monitoring in COPD : A consensus initiative for optimizing therapeutic appropriateness among Italian specialists

    Page :218-228

    Mario Cazzola, Vito Brusasco, Stefano Centanni, Isa Cerveri, Fausto De Michele, Giuseppe Di Maria, Paolo Palange, Riccardo Pellegrino, Mario Polverino, Andrea Rossi, Alberto Papi

    Résumé Résumé Plan Plan  
  • ·In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH₂) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator

    Page :229-238

    Jeffrey D. Edelson, Marie Makhlina, Kevin R. Silvester, Shailesh S. Vengurlekar, Xiaomei Chen, Jie Zhang, Cynthia J. Koziol-White, Philip R. Cooper, Trevor J. Hallam, Douglas W.P. Hay, Reynold A. Panettieri

    Résumé Résumé Plan Plan  
  • ·Levalbuterol versus albuterol for acute asthma: A systematic review and meta-analysis

    Page :239-248

    Kana Ram Jat, Anju Khairwa

    Résumé Résumé Plan Plan  
  • ·Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow^® rapid and PARI LC Plus^® nebulisers in cystic fibrosis patients

    Page :249-255

    Mirco Govoni, Gianluigi Poli, Daniela Acerbi, Debora Santoro, Helen Cicirello, Ottavia Annoni, Jozef Ružička

    Résumé Résumé Plan Plan  
  • ·Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD

    Page :256-264

    Rodger Kempsford, Virginia Norris, Sarah Siederer

    Résumé Résumé Plan Plan  
  • ·Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD

    Page :265-270

    Henrik Watz, Daniel Bock, Michael Meyer, Katrin Schierhorn, Karin Vollhardt, Christiane Woischwill, Frauke Pedersen, Anne Kirsten, Kai-Michael Beeh, Wolfgang Meyer-Sabellek, Helgo Magnussen, Jutta Beier

    Résumé Résumé Plan Plan  
  • ·Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lamb

    Page :271-280

    Shruti Sharma, Jubilee Barton, Ruslan Rafikov, Saurabh Aggarwal, Hsuan-Chang Kuo, Peter E. Oishi, Sanjeev A. Datar, Jeffrey R. Fineman, Stephen M. Black

    Résumé Résumé Plan Plan  
  • ·Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure

    Page :281-289

    Rainer Fuhst, Frank Runge, Jochen Buschmann, Heinrich Ernst, Christiane Praechter, Tanja Hansen, Jasmin von Erichsen, Agnieszka Turowska, Heinz-Gerd Hoymann, Meike Müller, Gerhard Pohlmann, Katherina Sewald, Christina Ziemann, Gerhard Schlüter, Holger Garn

    Résumé Résumé Plan Plan   
  • ·Transforming growth factor-beta1 and IL-13 response to allergen predict steroid needs in asthmatic children

    Page :290-295

    Paweł Majak, Dorota Jurałowicz, Joanna Jerzyńska, Katarzyna Smejda, Włodzimierz Stelmach, Iwona Stelmach

    Résumé Résumé Plan Plan  
  • ·Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation

    Page :296-304

    Bhawana Saluja, Jay N. Thakkar, Hua Li, Umesh R. Desai, Masahiro Sakagami

    Résumé Résumé Plan Plan